Paper33552157
Hypoxia Molecular Characterization in Hepatocellular Carcinoma Identifies One Risk Signature and Two Nomograms for Clinical Management.
Liu Z and 6 others. J Oncol, 2021. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Hypoxia Molecular Characterization in Hepatocellular Carcinoma Identifies One Risk Signature and Two Nomograms for Clinical Management. Papers, record 33552157. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33552157
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hypoxia Molecular Characterization in Hepatocellular Carcinoma Identifies One Risk Signature and Two Nomograms for Clinical Management.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28774834 | Role of Forkhead Box Class O proteins in cancer progression and metastasis. | Semin Cancer Biol | 2018 | https://conductscience.org/library/papers/28774834 | PubMed |
| 2 | 29170503 | Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma. | Nat Commun | 2017 | https://conductscience.org/library/papers/29170503 | PubMed |
| 3 | 25158761 | Critical limitations of consensus clustering in class discovery. | Sci Rep | 2014 | https://conductscience.org/library/papers/25158761 | PubMed |
| 4 | 23820108 | A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer. | Clin Cancer Res | 2013 | https://conductscience.org/library/papers/23820108 | PubMed |
| 5 | 29514782 | The MYC oncogene is a global regulator of the immune response. | Blood | 2018 | https://conductscience.org/library/papers/29514782 | PubMed |
| 6 | 32150830 | Obatoclax, a Pan-BCL-2 Inhibitor, Downregulates Survivin to Induce Apoptosis in Human Colorectal Carcinoma Cells Via Suppressing WNT/β-catenin Signaling. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32150830 | PubMed |
| 7 | 31537801 | DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load. | Nat Commun | 2019 | https://conductscience.org/library/papers/31537801 | PubMed |
| 8 | 32052444 | KIF18B promotes hepatocellular carcinoma progression through activating Wnt/β-catenin-signaling pathway. | J Cell Physiol | 2020 | https://conductscience.org/library/papers/32052444 | PubMed |
| 9 | 25601652 | VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors. | J Exp Med | 2015 | https://conductscience.org/library/papers/25601652 | PubMed |
| 10 | 24827502 | Hypoxia and the extracellular matrix: drivers of tumour metastasis. | Nat Rev Cancer | 2014 | https://conductscience.org/library/papers/24827502 | PubMed |
| 11 | 29443960 | TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. | Nature | 2018 | https://conductscience.org/library/papers/29443960 | PubMed |
| 12 | 30098600 | Role of hypoxia-induced exosomes in tumor biology. | Mol Cancer | 2018 | https://conductscience.org/library/papers/30098600 | PubMed |
| 13 | 29301958 | A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing. | Science | 2018 | https://conductscience.org/library/papers/29301958 | PubMed |
| 14 | 31350295 | The Tumor Microenvironment Innately Modulates Cancer Progression. | Cancer Res | 2019 | https://conductscience.org/library/papers/31350295 | PubMed |
| 15 | 23770567 | Mutational heterogeneity in cancer and the search for new cancer-associated genes. | Nature | 2013 | https://conductscience.org/library/papers/23770567 | PubMed |
| 16 | 30061739 | Molecular therapies and precision medicine for hepatocellular carcinoma. | Nat Rev Clin Oncol | 2018 | https://conductscience.org/library/papers/30061739 | PubMed |
| 17 | 29033130 | Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab. | Cell | 2017 | https://conductscience.org/library/papers/29033130 | PubMed |
| 18 | 28637793 | Endothelial cell metabolism in health and disease: impact of hypoxia. | EMBO J | 2017 | https://conductscience.org/library/papers/28637793 | PubMed |
| 19 | 26359337 | Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. | Science | 2015 | https://conductscience.org/library/papers/26359337 | PubMed |
| 20 | 28065785 | A positive feedback loop between ROS and Mxi1-0 promotes hypoxia-induced VEGF expression in human hepatocellular carcinoma cells. | Cell Signal | 2017 | https://conductscience.org/library/papers/28065785 | PubMed |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38632387 | Single-cell transcriptome analysis profiling lymphatic invasion-related TME in colorectal cancer. | Sci Rep | 2024 | https://conductscience.org/library/papers/38632387 | PubMed |
| 37365028 | [Construction of a prognostic model for hepatocellular carcinoma based on pyroptosis-related genes]. | Zhonghua Gan Zang Bing Za Zhi | 2023 | https://conductscience.org/library/papers/37365028 | PubMed |
| 37351165 | Comprehensive machine learning-generated classifier identifies pro-metastatic characteristics and predicts individual treatment in pancreatic cancer: A multicenter cohort study based on super-enhancer profiling. | Theranostics | 2023 | https://conductscience.org/library/papers/37351165 | PubMed |
| 36282174 | Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer. | Elife | 2022 | https://conductscience.org/library/papers/36282174 | PubMed |
| 35967384 | CD8+ T cell trajectory subtypes decode tumor heterogeneity and provide treatment recommendations for hepatocellular carcinoma. | Front Immunol | 2022 | https://conductscience.org/library/papers/35967384 | PubMed |
| 35967375 | Necroptosis throws novel insights on patient classification and treatment strategies for hepatocellular carcinoma. | Front Immunol | 2022 | https://conductscience.org/library/papers/35967375 | PubMed |
| 35662721 | Title: Multi-Omics and Immune Landscape of Proliferative LncRNA Signatures: Implications for Risk Stratification and Immunotherapy in Hepatocellular Carcinoma. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35662721 | PubMed |
| 35602471 | Identification and Validation of Immune Molecular Subtypes and Immune Landscape Based on Colon Cancer Cohort. | Front Med (Lausanne) | 2022 | https://conductscience.org/library/papers/35602471 | PubMed |
| 35317237 | Multi-omics landscape and clinical significance of a SMAD4-driven immune signature: Implications for risk stratification and frontline therapies in pancreatic cancer. | Comput Struct Biotechnol J | 2022 | https://conductscience.org/library/papers/35317237 | PubMed |
| 35250999 | Construction of a Lactate-Related Prognostic Signature for Predicting Prognosis, Tumor Microenvironment, and Immune Response in Kidney Renal Clear Cell Carcinoma. | Front Immunol | 2022 | https://conductscience.org/library/papers/35250999 | PubMed |
| 35211123 | The Effect of Hypoxia and Hypoxia-Associated Pathways in the Regulation of Antitumor Response: Friends or Foes? | Front Immunol | 2022 | https://conductscience.org/library/papers/35211123 | PubMed |
| 35145517 | Histone Acetylation Regulator-Mediated Acetylation Patterns Define Tumor Malignant Pathways and Tumor Microenvironment in Hepatocellular Carcinoma. | Front Immunol | 2022 | https://conductscience.org/library/papers/35145517 | PubMed |
| 35141223 | Methylation-Driven Gene PLAU as a Potential Prognostic Marker for Differential Thyroid Carcinoma. | Front Cell Dev Biol | 2022 | https://conductscience.org/library/papers/35141223 | PubMed |
| 35083217 | Immune Landscape Refines the Classification of Colorectal Cancer With Heterogeneous Prognosis, Tumor Microenvironment and Distinct Sensitivity to Frontline Therapies. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/35083217 | PubMed |
| 34977116 | Characterization of Two Ferroptosis Subtypes With Distinct Immune Infiltration and Gender Difference in Gastric Cancer. | Front Nutr | 2021 | https://conductscience.org/library/papers/34977116 | PubMed |
| 34970594 | An Integrated Fibrosis Signature for Predicting Survival and Immunotherapy Efficacy of Patients With Hepatocellular Carcinoma. | Front Mol Biosci | 2021 | https://conductscience.org/library/papers/34970594 | PubMed |
| 34970257 | CD8+ T Cell-Based Molecular Classification With Heterogeneous Immunogenomic Landscapes and Clinical Significance of Clear Cell Renal Cell Carcinoma. | Front Immunol | 2021 | https://conductscience.org/library/papers/34970257 | PubMed |
| 34899862 | Identification of the Immune Cell Infiltration Landscape in Hepatocellular Carcinoma to Predict Prognosis and Guide Immunotherapy. | Front Genet | 2021 | https://conductscience.org/library/papers/34899862 | PubMed |
| 34820372 | Identification of the Pyroptosis-Related Gene Signature for Overall Survival Prediction in Patients With Hepatocellular Carcinoma. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34820372 | PubMed |
| 34760703 | Computational Recognition and Clinical Verification of TGF-β-Derived miRNA Signature With Potential Implications in Prognosis and Immunotherapy of Intrahepatic Cholangiocarcinoma. | Front Oncol | 2021 | https://conductscience.org/library/papers/34760703 | PubMed |
Genes63
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33552157
GET https://conductscience.org/api/papers/v1/33552157/references?page=2